Sonnet BioTherapeutic | 10-K: FY2024 Annual Report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 424B5: Prospectus
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Director Bhatt Nailesh
Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Officer Dexter Susan
Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Director McNeill Lori
Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Director Dyrness Albert D.
Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Director Rao Raghu
Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Officer Cini John K.
Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Officer Mohan Pankaj
Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Officer Kenney Richard T
Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Officer Cross John Harry III
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 424B4: Prospectus
Sonnet BioTherapeutic | EFFECT: Others
Sonnet BioTherapeutic | CORRESP: CORRESP